Mechanisms of Complement-Mediated Damage in Hematological Disorders
Authors:
- 1 July 2018
- journal article
- review article
- Published by Elsevier in Seminars in Hematology
- Vol. 55 (3) , 118-123
Abstract
No abstract availableKeywords
This publication has 56 references indexed in Scilit:
- Terminal Complement Inhibitor Eculizumab in Atypical Hemolytic–Uremic SyndromeNew England Journal of Medicine, 2013
- Exhaustion of Cytotoxic Effector Systems May Limit Monoclonal Antibody-Based Immunotherapy in Cancer PatientsThe Journal of Immunology, 2012
- Penetration of antibody‐opsonized cells by the membrane attack complex of complement promotes Ca2+influx and induces streamersEuropean Journal of Immunology, 2011
- Thrombomodulin Mutations in Atypical Hemolytic–Uremic SyndromeNew England Journal of Medicine, 2009
- Factor H–mediated cell surface protection from complement is critical for the survival of PNH erythrocytesBlood, 2007
- Complement factor H and the hemolytic uremic syndromeJournal of Experimental Medicine, 2007
- Spontaneous hemolytic uremic syndrome triggered by complement factor H lacking surface recognition domainsJournal of Experimental Medicine, 2007
- Gain-of-function mutations in complement factor B are associated with atypical hemolytic uremic syndromeProceedings of the National Academy of Sciences, 2007
- Structure of complement factor H carboxyl‐terminus reveals molecular basis of atypical haemolytic uremic syndromeThe EMBO Journal, 2006
- Functional analysis in serum from atypical Hemolytic Uremic Syndrome patients reveals impaired protection of host cells associated with mutations in factor HMolecular Immunology, 2004